Use the Folding@home coronavirus repository conventions to curate molecular structures, prepare bounded OpenMM systems, and preserve target, publication, and provenance notes.
日本語の概要は準備中です。原文の説明を表示しています。
6 件 ・ 関連度順
概要と使いどころ
Use the Folding@home coronavirus repository conventions to curate molecular structures, prepare bounded OpenMM systems, and preserve target, publication, and provenance notes.
日本語の概要は準備中です。原文の説明を表示しています。
Scripts and configures production rendering in Autodesk 3ds Max with the V-Ray and Corona renderers: output size and files, render elements, denoising, light mix, batch and command-line rendering, and network rendering. Use when a user asks to set up a production render, render several cameras in one batch, render from the command line or on a render farm, add render passes for compositing, or cut render time for archviz and product shots.
日本語の概要は準備中です。原文の説明を表示しています。
Think and work like an expert Heliophysicist. Use when a task calls for Heliophysicist judgment. Reasons from MHD, magnetic topology, reconnection, and IMF Bz coupling through SDO/HMI magnetograms, DEM and NLFFF analysis, coronagraph GCS fitting, and WSA-ENLIL/EUHFORIA ensembles while treating LOS foreshortening, AIA stray light, force-free NLFFF breakdown, and Dst/SYM-H saturation as first-class failure modes.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a task needs the judgment of a board-certified cardiologist — triaging chest pain with a risk score, titrating heart-failure guideline-directed medical therapy, deciding revascularization strategy for stable or acute coronary disease, or working through anticoagulation decisions in atrial fibrillation. US practice default (ACC/AHA guideline framework). A reasoning aid, not medical advice.
日本語の概要は準備中です。原文の説明を表示しています。
Work a primary-prevention patient through the 2026 ACC/AHA multisociety dyslipidaemia guideline CPR framework — Calculate (10-year and 30-year PREVENT-ASCVD), Classify (low / borderline / intermediate / high), Personalize (demographic, clinical, biomarker, and reproductive risk enhancers), and Reclassify (coronary artery calcium scoring where appropriate). Use when a clinician asks how to assess ASCVD risk for primary prevention, who needs a statin, borderline risk patient what to do, intermediate risk should I start a statin, risk enhancers to look for, premature family history of ASCVD how does it change risk, pregnancy-related risk factors, PCOS and cardiovascular risk. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.
日本語の概要は準備中です。原文の説明を表示しています。
Decide when to order coronary artery calcium (CAC) scoring in a primary-prevention patient and interpret the result per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers the Class 1 indication (men ≥40 / women ≥45, borderline / intermediate PREVENT-ASCVD risk, uncertainty about LLT), CAC score interpretation (0, 1–99, 100–299, ≥300, ≥1000), how CAC modifies LDL and non-HDL goals, when to repeat CAC, and pitfalls (incidental CAC on non-cardiac CT, radiation, cost). Use when a clinician asks should I order a CAC score, CAC indications, what does CAC 150 mean, treatment goals with CAC score, repeat CAC frequency, CAC in a smoker, CAC vs CCTA, is CAC useful in intermediate risk. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.
日本語の概要は準備中です。原文の説明を表示しています。